X0306 4 2017-08-03 1 0001273636 APPLIED GENETIC TECHNOLOGIES CORP AGTC 0001206868 BULLOCK LAWRENCE E C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE #10 ALACHUA FL 32615 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 4.50 2017-08-03 4 A 0 4168 0.00 A 2027-08-03 Common Stock 4168 4168 D Option became exercisable for 25% on August 3, 2017, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments on the last day of each calendar month beginning August 31, 2017 and ending October 31, 2017, as long as Mr. Bullock continues to be employed with Applied Genetic Technologies Corporation and with no further vesting after his employment ends. /s/ Hemmie Chang, attorney-in-fact 2017-08-09